Saint Joseph, MO2 Active Studies

Ankylosing Spondylitis Clinical Trials in Saint Joseph, MO

Find 2 actively recruiting ankylosing spondylitis clinical trials in Saint Joseph, MO. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
11,045
Enrolling

Recruiting Ankylosing Spondylitis Studies in Saint Joseph

About Ankylosing Spondylitis Clinical Trials in Saint Joseph

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Saint Joseph, MO. These studies are seeking a combined 11,045 participants. Research is being sponsored by Boehringer Ingelheim, Bausch Health Americas, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Saint Joseph — FAQ

Are there ankylosing spondylitis clinical trials in Saint Joseph?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Saint Joseph, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Saint Joseph?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Saint Joseph research site will contact you about next steps.

Are clinical trials in Saint Joseph free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Saint Joseph studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Saint Joseph are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov